\nComitetul pentru medicamente de uz uman (CHMP) a recomandat darolutamida, un inhibitor oral al receptorului androgenic, asociat cu terapia de deprivare androgenic\u0103 (ADT).<\/p>\n
\nDecizia final\u0103 a Comisiei Europene este a\u015fteptat\u0103 \u00een urm\u0103toarele luni.<\/p>\n
\nRecomandarea se bazeaz\u0103 pe rezultatele studiului de \u00eenregistrare de faz\u0103 3 \u201eAranote”, care arat\u0103 c\u0103 darolutamida plus ADT a redus riscul de progresie radiologic\u0103 sau deces cu 46% comparativ cu placebo, conform ANSA.<\/p>\n
\n\u201e\u00cen 2024, \u00een Italia, s-au estimat aproximativ 40.200 de noi cazuri de cancer de prostat\u0103, cel mai frecvent cancer la b\u0103rba\u0163i \u00een \u0163ara noastr\u0103”, afirm\u0103 Orazio Caffo, directorul sec\u0163iei de oncologie de la Spitalul Santa Chiara din Trento.<\/p>\n
\nCaffo explic\u0103 c\u0103 impactul cancerului de prostat\u0103 metastatic asupra vie\u0163ii de zi cu zi a pacien\u0163ilor poate fi semnificativ. \u201eStudiul Aranote a demonstrat c\u0103 darolutamida reduce semnificativ riscul de progresie radiologic\u0103 sau de deces. Acest inhibitor al receptorilor androgenici a demonstrat beneficii importante \u015fi \u00een ceea ce prive\u015fte calitatea vie\u0163ii”, a ad\u0103ugat specialistul.<\/p>\n
\nNoua terapie extinde instrumentele disponibile medicilor pentru tratarea unei forme de cancer de prostat\u0103 deosebit de agresiv\u0103, permi\u0163\u00e2nd personalizarea tratamentelor \u015fi cre\u015fterea \u015fanselor pentru fiecare pacient.<\/p>\n
\nCancerul de prostat\u0103, cu peste 40.000 de cazuri diagnosticate anual, este cel mai frecvent cancer la b\u0103rba\u0163ii din Italia \u015fi a cincea cauz\u0103 de deces prin cancer la b\u0103rba\u0163i la nivel global.<\/p>\n","protected":false},"excerpt":{"rendered":"
O nou\u0103 combina\u0163ie de medicamente va fi disponibil\u0103 \u00een cur\u00e2nd pentru pacien\u0163ii cu cancer de prostat\u0103 metastatic hormono-sensibil, dup\u0103 ce Agen\u0163ia European\u0103 pentru Medicamente a recomandat autorizarea comercializ\u0103rii \u00een UE.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[14610,44761],"class_list":["post-237870","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cancer","tag-prostata"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/237870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=237870"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/237870\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=237870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=237870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=237870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}